Document is current
Any future updates will be listed below
-
Authors
Weyand, Cornelia M. https://orcid.org/0000-0003-2230-9802
Goronzy, Jörg J. https://orcid.org/0000-0001-7670-1856
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR042527)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI184360)
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 6 June 2025
First Online: 14 August 2025
Competing interests
: C.M.W. has received consulting fees from AbbVie, Bristol Myers Squibb, Novartis, Ono Pharmaceutical, Boehringer Ingelheim and Sparrow Pharmaceuticals. J.J.G. has received consulting fees and stock options from Retro Biosciences.
